Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences: Selective literature review
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Background: Hyperprolactinaemia has for decades been an inevitable and neglected side-effect of antipsychotic medication. The recent introduction of prolactin-sparing antipsychotic agents makes a re-examination of this problem timely. Aims: To review the literature on antipsychotic-induced hyperprolactinaemia and its consequences. Method: A search was made of the Medline database (1966–2002) for key articles, supplemented by cross-referencing. Results: During antipsychotic treatment prolactin concentrations can rise to ten times normal levels or above, and existing data indicate that 17–78% of female patients have amenorrhoea with or without galactorrhoea. Survey data, however, suggest that clinicians underestimate the prevalence of these conditions. Long-term consequences of antipsychotic-related hypo-oestrogenism require further research but are likely to include premature bone loss. Conclusions: Antipsychotic-induced hyperprolactinaemia should become a focus of interest in the drug treatment of psychiatric patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bole-Feysot, C., Goffin, V., Edery, M., Binart, N., & Kelly, P. A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0334 · Cited by 1,938 · cited 1×
“Binding sites for prolactin are widely distributed in the body and several hundred different actions have been described, at least in vertebrate animals (Bole-Feysot et al, 1998).”
Kapur, S., & Seeman, P. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.360 · Cited by 1,140 · cited 1×
“These include a relative limbic selectivity of these agents, a separation of dose and response between pharmacological functions, interactions with neurotransmitter receptors other than D2, and the binding dynamics at the D2 receptor (Kapur & Seeman, 2001).”
Parfitt, A. M. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550303 · Cited by 1,001 · cited 1×
“It has been estimated that in humans as much as 25% of trabecular bone and 3% of cortical bone are resorbed and replaced each year (Parfitt, 1994).”
Arvanitis, L. A., & Miller, B. G. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00190-x · Cited by 803
Peuskens, J. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.166.6.712 · Cited by 551 · cited 1×
“The latter method was used in an earlier report for a subgroup of the same study population (Peuskens, 1995).”
Neurotransmitter regulation of anterior pituitary hormones.
Tuomisto, J., & Männistö, P. T. (1985) · PubMed · Cited by 531
Quetiapine in Patients With Schizophrenia: A High- and Low-Dose Double-blind Comparison With Placebo
Small, J. G. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830180067009 · Cited by 478
The Bone Density of Female Twins Discordant for Tobacco Use
Hopper, J. L., & Seeman, E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402103300603 · Cited by 392
Prolactin Levels and Adverse Events in Patients Treated with Risperidone
Kleinberg, D. L., Davis, J. M., de Coster, R., Van Baelen, B., & Brecher, M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00011 · Cited by 307 · cited 3×
“The low rate of galactorrhoea in the study by Kleinberg et al (1999) – 2.4% in women treated with risperidone and 2.2% in women treated with haloperidol – may be an underestimate for the same reasons as described for the analysis of amenorrhoea.”
InfluentialThe Effect of Neuroleptics on Serum Prolactin in Schizophrenic Patients
Meltzer, H. Y. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770030003001 · Cited by 294
Cited by
Antipsychotic-Induced Hyperprolactinaemia: Mechanisms, Clinical Features and Management
Haddad, P. M., & Wieck, A. (2004) · Drugs · doi:10.2165/00003495-200464200-00003 · Cited by 634
Self-citationMeaney, A. M., Smith, S., Howes, O. D., O'Brien, M., Murray, R. M., & O'Keane, V. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.503 · Cited by 217
Byerly, M., Suppes, T., Tran, Q.-V., & Baker, R. A. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815ac4e5 · Cited by 153
“that prolactin levels in antipsychotic-naive patients with schizophrenia or bipolar spectrum disorders appear to be comparable with those observed in the general population.(13) Elevated prolactin levels in patients receiving antipsychotic medications are therefore likely to be attributable to the medication rather th…”
ResultCohrs, S., Röher, C., Jordan, W., Meier, A., Huether, G., Wuttke, W., Rüther, E., & Rodenbeck, A. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0279-x · Cited by 141
Risk of hip/femur fractures in patients using antipsychotics
Hugenholtz, G. W. K., Heerdink, E. R., van Staa, T. P., Nolen, W. A., & Egberts, A. C. G. (2005) · Bone · doi:10.1016/j.bone.2005.07.005 · Cited by 77
“Which is probably caused by the effect of antipsychotics on decreasing bone mineralization, leading to weaker bones [3,5,12,21,25,39].”
Background
Metadata
- Authors
- Wieck, A., & Haddad, P. M.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2003-03
- Volume
- 182
- Issue
- 3
- Pages
- 199-204
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W1973003196
- Cited by
- 167
- References
- 62
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.